PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
04-Mar-2024 AbTherx Announces Transition from Early Access to Commercialization of its Bispecific and Full Human Diversity Antibody Discovery Technologies AccessWire
04-Mar-2024 Soft Tissue Market Predicted to Expand at 4.9% CAGR, Reaching USD 23 Billion by 2033 Wired Release
04-Mar-2024 Heidelberg Pharma Announces Royalty Financing Agreement with HealthCare Royalty for up to USD 115 million Heidelberg Pharma AG
04-Mar-2024 Heidelberg Pharma Announces Royalty Financing Agreement with HealthCare Royalty for up to USD 115 million Heidelberg Pharma AG
04-Mar-2024 MindBio Therapeutics Receives Final Regulatory Approval to Conduct Phase 2B Randomised Controlled Trial Microdosing Mb22001 in Patients Diagnosed with Major Depressive Disorder AccessWire
04-Mar-2024 Carthera: positive results from phase I/II clinical trial of SonoCloud-9 in treatment of glioblastoma published in Nature Communications Andrew Lloyd Associates
04-Mar-2024 Neurovascular Guidewires Market Poised for Exponential Growth, Projected to reach USD 331.1 Million by 2033 Wired Release
04-Mar-2024 Phoropters Market Expected to Reach New Heights, Reaching USD 160.5 Million by 2033 Wired Release
04-Mar-2024 Redeye Initiates Coverage of PMD Device Solutions AccessWire
04-Mar-2024 Veterinary Supplements Market Set to Double in Size, Projected Worth USD 4.1 Billion by 2033 Wired Release
04-Mar-2024 BioNxt Reports Completion of ODF Cladribine PK Study AccessWire
04-Mar-2024 Dialysis Equipment Market Set to Surge, Expected to Hit USD 27.2 Billion by 2033 Wired Release
04-Mar-2024 Microcatheter Market Poised for Robust Growth, Expected to Reach USD 2.0 Billion by 2033 Wired Release
04-Mar-2024 DEFENCE THERAPEUTICS AWARDED BROAD U.S. PATENT COVERING ITS PIONEERING CANCER-KILLING ACCUTOX® TECHNOLOGY Defence Therapeutics Inc.
04-Mar-2024 CRISPR Technology Market Projected to Surge to USD 15 Billion by 2033, Driven by Remarkable Growth Rate Wired Release
04-Mar-2024 Q&M Dental Group recorded growth in both Revenue and Net Profit after tax attributable to parent of S$182.7 million and S$11.5 million respectively for FY2023 Q&M Dental Group Singapore Ltd
04-Mar-2024 Alfa Chemistry Diversifies Supply of Active Pharmaceutical Ingredients for Pharmaceutical Preparation Alfa Chemistry
04-Mar-2024 Alfa Chemistry Expands Selection of Click Chemistry Reagents: DBCO, BCN, and Tetrazines Included Alfa Chemistry
02-Mar-2024 Dr. Robert T. Hoover II Joins Central Florida Foot & Ankle Institute’s New Location in AdventHealth Apopka’s Medical Plaza AccessWire
02-Mar-2024 Brüush Receives Nasdaq Delisting Notification and Files to Appeal AccessWire